sulfasalazine has been researched along with Venous Thrombosis in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Venous Thrombosis: The formation or presence of a blood clot (THROMBUS) within a vein.
Excerpt | Relevance | Reference |
---|---|---|
" In an attempt to treat arthritis, her gastroenterologist replaced 5-aminosalicylic acid (5-ASA) with sulfasalazine 1000 mg four times daily." | 3.70 | Warfarin resistance due to sulfasalazine. ( Kovacs, MJ; Martin, JE; Teefy, AM, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Teefy, AM | 1 |
Martin, JE | 1 |
Kovacs, MJ | 1 |
1 other study available for sulfasalazine and Venous Thrombosis
Article | Year |
---|---|
Warfarin resistance due to sulfasalazine.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthritis; Drug Administration Sched | 2000 |